Factors Associated With Discharge After Initial Emergency Treatment of Pediatric Migraine

Bhooma R Aravamuthan1, Soe Soe Mar, Kristine G Williams

  • 1From the *St. Louis Children's Hospital; and Department of †Neurology, and ‡Pediatrics Washington University in St. Louis, St. Louis, MO.

Pediatric Emergency Care
|September 12, 2015
PubMed

Insights

Pediatric emergency department migraine treatment effectiveness varies. Higher discharge rates were seen with intravenous medications, particularly ketorolac and antiemetics, compared to oral or intranasal options.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Pharmacology
  • Pain Management

Background:

  • Migraine treatment protocols in pediatric emergency departments (EDs) show significant variability.
  • Identifying factors that predict successful discharge after initial treatment is crucial for optimizing care.

Purpose of the Study:

  • To examine patient characteristics and initial treatments associated with discharge after only initial emergency department migraine treatment.
  • To inform evidence-based guidelines for pediatric migraine management in the ED.

Main Methods:

  • Retrospective chart analysis of 700 pediatric patients (6-18 years) diagnosed with migraine between 2008-2011.
  • Generalized linear models and receiver operating characteristic curves were used to analyze associations between treatments and discharge rates.

Main Results:

  • Intravenous (IV) medications, especially ketorolac with an antiemetic, were associated with higher discharge rates than oral/intranasal (PO/IN) medications.
  • Ibuprofen alone was linked to lower discharge rates compared to other PO/IN regimens.
  • Arrival pain score was a significant predictor of discharge, with different thresholds for ibuprofen versus other PO/IN or IV treatments.

Conclusions:

  • Arrival pain scores can guide the selection of initial migraine treatments in pediatric EDs.
  • Consideration of PO/IN regimens with triptans or antiemetics, and IV ketorolac with an antiemetic, may improve discharge rates after initial treatment.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
377
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.3K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
474
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
745
Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.4K